Identification of three immune molecular subtypes associated with immune profiles, immune checkpoints, and clinical outcome in multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of three immune molecular subtypes associated with immune profiles, immune checkpoints, and clinical outcome in multiple myeloma

Published:2021-08-21 Issue:20 Volume:10 Page:7395-7403
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Gao Guangtao¹^ORCID,Fang Mengkun¹,Xu Peipei¹^ORCID,Chen Bing¹

Affiliation:

1. Department of Hematology The Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing Jiangsu China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4221

Reference47 articles.

1. Multiple myeloma

2. Multiple myeloma

3. New Drugs in Multiple Myeloma

4. Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020

5. Immunotherapy of multiple myeloma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the clinical role and prognostic value of genes related to insulin-like growth factor signaling pathway in thyroid cancer;Aging;2024-02-07

2. Identification of an angiogenesis-related risk score model for survival prediction and immunosubtype screening in multiple myeloma;Aging;2024-02-05

3. CD74 is associated with inflamed tumor immune microenvironment and predicts responsiveness to PD-1/CTLA-4 bispecific antibody in patients with solid tumors;Cancer Immunology, Immunotherapy;2024-01-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3